Invesco Ltd. Purchases 6,957 Shares of Chemed Co. (NYSE:CHE)

Invesco Ltd. increased its position in Chemed Co. (NYSE:CHE) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,144 shares of the company’s stock after purchasing an additional 6,957 shares during the period. Invesco Ltd. owned 1.21% of Chemed worth $96,500,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CHE. Raymond James Financial Inc. bought a new stake in Chemed during the fourth quarter worth about $42,023,000. Geode Capital Management LLC lifted its holdings in shares of Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after purchasing an additional 15,791 shares during the last quarter. Signal Advisors Wealth LLC lifted its holdings in shares of Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after purchasing an additional 1,886 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Chemed by 10.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company’s stock worth $72,149,000 after purchasing an additional 13,394 shares in the last quarter. Finally, Bright Rock Capital Management LLC bought a new position in Chemed during the 4th quarter valued at approximately $1,060,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Up 0.2 %

Shares of NYSE CHE opened at $591.44 on Monday. The company has a 50 day moving average of $583.16 and a 200 day moving average of $567.72. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $625.09. The firm has a market cap of $8.64 billion, a P/E ratio of 29.89, a PEG ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is currently 10.05%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on CHE shares. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada increased their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research report on Friday, March 14th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.